Gaolei Liu

890 total citations
28 papers, 699 citations indexed

About

Gaolei Liu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Gaolei Liu has authored 28 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Gaolei Liu's work include Cancer, Hypoxia, and Metabolism (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Renal cell carcinoma treatment (4 papers). Gaolei Liu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Renal cell carcinoma treatment (4 papers). Gaolei Liu collaborates with scholars based in China, United States and Hong Kong. Gaolei Liu's co-authors include Dali Tong, Jun Jiang, Dianzheng Zhang, Qiuli Liu, Weihua Lan, Jing Xu, Luofu Wang, Lin-ang Wang, Hualiang Xiao and Yiqiang Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hazardous Materials and Clinical Cancer Research.

In The Last Decade

Gaolei Liu

27 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaolei Liu China 12 395 241 206 161 85 28 699
Yong‐Chuan Wong Hong Kong 17 659 1.7× 272 1.1× 220 1.1× 136 0.8× 64 0.8× 27 945
Zhiqing Fang China 14 285 0.7× 124 0.5× 213 1.0× 158 1.0× 89 1.0× 30 587
Yong Luo China 15 458 1.2× 308 1.3× 250 1.2× 154 1.0× 52 0.6× 35 806
C-W Wu Taiwan 10 283 0.7× 168 0.7× 159 0.8× 86 0.5× 102 1.2× 10 595
LaMonica V. Stewart United States 17 477 1.2× 156 0.6× 207 1.0× 172 1.1× 34 0.4× 28 793
Weilong Chang China 17 340 0.9× 227 0.9× 170 0.8× 121 0.8× 134 1.6× 32 668
Bryan M. Gillard United States 12 320 0.8× 137 0.6× 111 0.5× 124 0.8× 28 0.3× 25 615
Pilar Martínez-Onsurbe Spain 15 265 0.7× 115 0.5× 129 0.6× 164 1.0× 76 0.9× 22 596

Countries citing papers authored by Gaolei Liu

Since Specialization
Citations

This map shows the geographic impact of Gaolei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaolei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaolei Liu more than expected).

Fields of papers citing papers by Gaolei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaolei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaolei Liu. The network helps show where Gaolei Liu may publish in the future.

Co-authorship network of co-authors of Gaolei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Gaolei Liu. A scholar is included among the top collaborators of Gaolei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaolei Liu. Gaolei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Yang, Mingfeng Zhao, Xinyi Liu, et al.. (2025). Clinical features and therapeutic experiences of renal cancer related to Xp11.2 translocation/TFE3 gene fusion: A case series of 18 patients. Pathology - Research and Practice. 271. 156052–156052.
2.
Wang, Lu, et al.. (2024). NUA4 histone acetylase gene LeEaf6 regulates precocity of shiitake mushroom, Lentinula edodes. Scientia Horticulturae. 328. 112912–112912. 1 indexed citations
3.
Liu, Gaolei, Hao Luo, Dandan Liang, et al.. (2024). Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Tumor Immune Infiltration in Bladder Cancer. Recent Patents on Anti-Cancer Drug Discovery. 20(2). 185–199. 1 indexed citations
4.
Guo, Mengpei, Xiaolong Ma, Yan Zhou, et al.. (2023). Genome Sequencing Highlights the Plant Cell Wall Degrading Capacity of Edible Mushroom Stropharia rugosoannulata. The Journal of Microbiology. 61(1). 83–93. 7 indexed citations
5.
Tang, Peng, Jun Zhang, Peng Song, et al.. (2023). Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations. BMC Endocrine Disorders. 23(1). 77–77. 4 indexed citations
6.
Luo, Hao, Gaolei Liu, Dan Jian, et al.. (2022). Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade. Journal of Immunology Research. 2022. 1–21. 1 indexed citations
7.
Liu, Qiuli, Jian Pang, Jing Xu, et al.. (2020). Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2. The Journal of Pathology. 253(1). 106–118. 48 indexed citations
8.
Tang, Tang, Lin-ang Wang, Peng Wang, et al.. (2020). Case Report: Co-Existence of BRCA2 and PALB2 Germline Mutations in Familial Prostate Cancer With Solitary Lung Metastasis. Frontiers in Oncology. 10. 564694–564694. 5 indexed citations
9.
Tang, Tang, Jian Pang, Jing Xu, et al.. (2020). LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT. Frontiers in Oncology. 10. 1234–1234. 34 indexed citations
10.
Pang, Jian, Lin-ang Wang, Jing Xu, et al.. (2019). A Renal Cell Carcinoma with Biallelic Somatic TSC2 Mutation: Clinical Study and Literature Review. Urology. 133. 96–102. 5 indexed citations
11.
Liu, Qiuli, Dali Tong, Gaolei Liu, et al.. (2018). Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration. Clinical Cancer Research. 24(22). 5622–5634. 86 indexed citations
12.
Yuan, Gang, Qiuli Liu, Dali Tong, et al.. (2018). A retrospective case study of sunitinib treatment in three patients with Von Hippel-Lindau disease. Cancer Biology & Therapy. 19(9). 766–772. 10 indexed citations
13.
Tong, Dali, Qiuli Liu, Lin-ang Wang, et al.. (2018). The roles of the COX2/PGE2/EP axis in therapeutic resistance. Cancer and Metastasis Reviews. 37(2-3). 355–368. 84 indexed citations
14.
Liu, Qiuli, Yan Wang, Dali Tong, et al.. (2017). A Somatic HIF2α Mutation-Induced Multiple and Recurrent Pheochromocytoma/Paraganglioma with Polycythemia: Clinical Study with Literature Review. Endocrine Pathology. 28(1). 75–82. 10 indexed citations
15.
Liu, Qiuli, Dali Tong, Gaolei Liu, et al.. (2017). HIF2Agermline–mutation-induced polycythemia in a patient with VHL-associated renal-cell carcinoma. Cancer Biology & Therapy. 18(12). 944–947. 11 indexed citations
16.
Liu, Qiuli, Dali Tong, Gaolei Liu, et al.. (2017). Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT. Cell Death and Disease. 8(8). e3007–e3007. 88 indexed citations
17.
Liu, Qiuli, Dali Tong, Gaolei Liu, et al.. (2017). Different RET gene mutation-induced multiple endocrine neoplasia type 2A in 3 Chinese families. Medicine. 96(3). e5967–e5967. 10 indexed citations
18.
Liu, Qiuli, Dali Tong, Gaolei Liu, et al.. (2017). Carney complex with PRKAR1A gene mutation. Medicine. 96(50). e8999–e8999. 16 indexed citations
19.
Tong, Dali, Qiuli Liu, Gaolei Liu, et al.. (2016). Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis. Cancer Letters. 389. 23–32. 106 indexed citations
20.
Wang, Yan, et al.. (2015). Metformin represses androgen‐dependent and androgen‐independent prostate cancers by targeting androgen receptor. The Prostate. 75(11). 1187–1196. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026